 |
|
Risk Factors for Hospital-Acquired Staphylococcus aureus Bacteremia
Allan G. Jensen, MD;
Carsten H. Wachmann, MSc, PhD;
Kjeld B. Poulsen, MD, PhD;
Frank Espersen, MD, PhD;
Jens Scheibel, MD;
Peter Skinhøj, MD, PhD;
Niels Frimodt-Møller, MD, PhD
Arch Intern Med. 1999;159:1437-1444.
Background Staphylococcus aureus bacteremia (SAB) acquired in hospitals continues to be a frequent and serious complication to hospitalization, and no previous case-control studies dealing with risk factors of this severe disease are available.
Methods Based on a 1-year prospective analysis, the data from all patients with hospital-acquired SAB admitted to 4 hospitals in Copenhagen County, Denmark, from May 1, 1994, through April 30, 1995, were evaluated. Eighty-five patients with hospital-acquired SAB were matched to 85 control patients with a similar primary diagnosis at admission (matched controls). Of these, 62 patients with hospital-acquired SAB were compared with 118 other patients with a similar time of admission, who were randomly selected with no clinical evidence of SAB (unmatched controls).
Results The incidence of hospital-acquired SAB was 0.71 per 1000 hospital admissions. The presence of a central venous catheter (odds ratio, 6.9; 95% confidence interval [CI], 2.8-17.0), anemia (odds ratio, 3.3; 95% CI, 1.4-7.6), and hyponatremia (odds ratio, 3.3; 95% CI, 1.5-7.0) was significantly associated with hospital-acquired SAB in a conditional and a usual logistic regression analysis. Nasal carriage was not an independent risk factor, but nasal carriers among patients in surgery (odds ratio, 4.0; 95% CI, 1.3-13.0) had a significantly higher risk for hospital-acquired SAB compared with matched and unmatched controls. The presence of hospital-acquired SAB increased the mortality rate 2.4-fold (95% CI, 1.1-5.2).
Conclusions The presence of a central venous catheter is an important risk factor, and hyponatremia and anemia are associated with the development of hospital-acquired SAB. Furthermore, hospital-acquired SAB in itself increases mortality.
From the Sector for Microbiology (Drs Jensen, Poulsen, Espersen, and Frimodt-Møller) and the Biostatistical Unit (Dr Wachmann), Statens Serum Institut; the Department of Clinical Microbiology, Herlev University Hospital (Dr Scheibel); and the Department of Infectious Diseases, Rigshospitalet (Dr Skinhøj), Copenhagen, Denmark.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(13):1503.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials
Falagas et al.
Nephrol Dial Transplant 2006;21:2536-2542.
ABSTRACT
| FULL TEXT
Administrative data based patient safety research: a critical review
Zhan and Miller
Qual Saf Health Care 2003;12:ii58-63.
ABSTRACT
| FULL TEXT
Excess Length of Stay, Charges, and Mortality Attributable to Medical Injuries During Hospitalization
Zhan and Miller
JAMA 2003;290:1868-1874.
ABSTRACT
| FULL TEXT
Treatment and Outcome of Staphylococcus aureus Bacteremia: A Prospective Study of 278 Cases
Jensen et al.
Arch Intern Med 2002;162:25-32.
ABSTRACT
| FULL TEXT
In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis
Boucher et al.
Antimicrob. Agents Chemother. 2001;45:208-211.
ABSTRACT
| FULL TEXT
Update in Hospital Medicine
Hauer and Winawer
ANN INTERN MED 2000;133:707-713.
FULL TEXT
In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria
Boucher et al.
Antimicrob. Agents Chemother. 2000;44:2225-2229.
ABSTRACT
| FULL TEXT
|
